140 related articles for article (PubMed ID: 11423326)
1. Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus).
Dühlmeier R; Deegen E; Fuhrmann H; Widdel A; Sallmann HP
Comp Biochem Physiol A Mol Integr Physiol; 2001 Jun; 129(2-3):563-75. PubMed ID: 11423326
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the oral glucose and sugar tolerance tests and the enteroinsular axis response in healthy adult donkeys.
Mendoza FJ; Buzon-Cuevas A; Toribio RE; Perez-Ecija A
Equine Vet J; 2022 Nov; 54(6):1123-1132. PubMed ID: 34897779
[TBL] [Abstract][Full Text] [Related]
3. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
[TBL] [Abstract][Full Text] [Related]
4. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
Füessl HS; Yiangou Y; Ghatei MA; Goebel FD; Bloom SR
Eur J Clin Invest; 1990 Oct; 20(5):525-9. PubMed ID: 2124984
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
6. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
7. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
[TBL] [Abstract][Full Text] [Related]
8. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
9. Insulin and incretin responses to grazing in insulin-dysregulated and healthy ponies.
Fitzgerald DM; Walsh DM; Sillence MN; Pollitt CC; de Laat MA
J Vet Intern Med; 2019 Jan; 33(1):225-232. PubMed ID: 30506731
[TBL] [Abstract][Full Text] [Related]
10. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
11. Effects of body weight gain on insulin and lipid metabolism in equines.
Blaue D; Schedlbauer C; Starzonek J; Gittel C; Brehm W; Einspanier A; Vervuert I
Domest Anim Endocrinol; 2019 Jul; 68():111-118. PubMed ID: 31035090
[TBL] [Abstract][Full Text] [Related]
12. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
Takemura J; Seino Y; Yamamura T; Yoshiya K; Ishikawa Y; Itoh N; Imura H
Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
[TBL] [Abstract][Full Text] [Related]
13. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
14. Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas.
Beuschlein F; Borgemeister M; Schirra J; Göke B; Fassnacht M; Arlt W; Allolio B; Reincke M
Clin Endocrinol (Oxf); 2000 May; 52(5):617-23. PubMed ID: 10792342
[TBL] [Abstract][Full Text] [Related]
15. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
[TBL] [Abstract][Full Text] [Related]
16. Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss.
Jones IR; Owens DR; Luzio SD; Hayes TM
Diabete Metab; 1989; 15(1):11-22. PubMed ID: 2721810
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
Theodorakis MJ; Carlson O; Muller DC; Egan JM
Diabetes Care; 2004 Jul; 27(7):1692-8. PubMed ID: 15220248
[TBL] [Abstract][Full Text] [Related]
18. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
Sarson DL; Kopelman PG; Besterman HS; Pilkington TR; Bloom SR
Diabetologia; 1983 Nov; 25(5):386-91. PubMed ID: 6360777
[TBL] [Abstract][Full Text] [Related]
19. Enteroinsular axis response to carbohydrates and fasting in healthy newborn foals.
Rings LM; Swink JM; Dunbar LK; Burns TA; Toribio RE
J Vet Intern Med; 2019 Nov; 33(6):2752-2764. PubMed ID: 31664736
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in metabolic syndrome.
Calanna S; Urbano F; Piro S; Zagami RM; Di Pino A; Spadaro L; Purrello F; Rabuazzo AM
Eur J Endocrinol; 2012 May; 166(5):917-22. PubMed ID: 22391044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
